QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
QIAGEN (NYSE: QGEN) has announced the opening of a new data center in Melbourne, Australia, expanding its global bioinformatics infrastructure to eight facilities worldwide. The new center will serve the Australia/Asia-Pacific region, including Australia, New Zealand, New Guinea, and surrounding islands.
The Melbourne facility joins QIAGEN's existing network of data centers in the United States, United Kingdom, Denmark, Turkey, South Korea, Japan, and China. It will provide in-country data hosting services, enabling genomic testing laboratories to comply with Australian privacy and health data regulations while securely managing sensitive data.
QIAGEN Digital Insights currently serves 90,000 users worldwide and has profiled 4 million patient cases over its 25-year history in the industry. The expansion demonstrates QIAGEN's commitment to supporting clinical next-generation sequencing (NGS) testing services and ensuring data security, compliance, and operational excellence globally.
QIAGEN (NYSE: QGEN) ha annunciato l'apertura di un nuovo centro dati a Melbourne, Australia, ampliando la sua infrastruttura globale di bioinformatica a otto strutture in tutto il mondo. Il nuovo centro servirà la regione Australia/Asia-Pacifico, compresi Australia, Nuova Zelanda, Nuova Guinea e isole circostanti.
La struttura di Melbourne si unisce alla rete esistente di centri dati di QIAGEN negli Stati Uniti, Regno Unito, Danimarca, Turchia, Corea del Sud, Giappone e Cina. Fornirà servizi di hosting dei dati nel paese, consentendo ai laboratori di test genetici di conformarsi alle normative australiane sulla privacy e sui dati sanitari, gestendo in modo sicuro i dati sensibili.
QIAGEN Digital Insights attualmente serve 90.000 utenti in tutto il mondo e ha profilato 4 milioni di casi di pazienti nel corso dei suoi 25 anni di storia nel settore. L'espansione dimostra l'impegno di QIAGEN nel supportare i servizi di testing clinico di sequenziamento di nuova generazione (NGS) e garantire la sicurezza dei dati, la conformità e l'eccellenza operativa a livello globale.
QIAGEN (NYSE: QGEN) ha anunciado la apertura de un nuevo centro de datos en Melbourne, Australia, ampliando su infraestructura global de bioinformática a ocho instalaciones en todo el mundo. El nuevo centro atenderá la región de Australia/Asia-Pacífico, incluidos Australia, Nueva Zelanda, Nueva Guinea y las islas circundantes.
La instalación de Melbourne se une a la red existente de centros de datos de QIAGEN en Estados Unidos, Reino Unido, Dinamarca, Turquía, Corea del Sur, Japón y China. Proporcionará servicios de alojamiento de datos en el país, permitiendo que los laboratorios de pruebas genómicas cumplan con las regulaciones australianas sobre privacidad y datos de salud, mientras gestionan de manera segura datos sensibles.
QIAGEN Digital Insights actualmente atiende a 90,000 usuarios en todo el mundo y ha perfilado 4 millones de casos de pacientes a lo largo de sus 25 años de historia en la industria. La expansión demuestra el compromiso de QIAGEN de apoyar los servicios de pruebas clínicas de secuenciación de nueva generación (NGS) y asegurar la seguridad de los datos, el cumplimiento y la excelencia operacional a nivel global.
QIAGEN (NYSE: QGEN)은 호주 멜버른에 새로운 데이터 센터를 개소했다고 발표하며, 전 세계적으로 8개의 시설로 확장된 글로벌 생물정보학 인프라를 자랑합니다. 새로운 센터는 호주, 뉴질랜드, 뉴기니 및 주변 섬을 포함한 호주/아시아-태평양 지역에 서비스를 제공합니다.
멜버른 시설은 미국, 영국, 덴마크, 터키, 한국, 일본 및 중국에 위치한 QIAGEN의 기존 데이터 센터 네트워크에 합류합니다. 이 시설은 국내 데이터 호스팅 서비스를 제공하여 유전자 검사 실험실이 호주의 개인 정보 및 건강 데이터 규정을 준수하고 민감한 데이터를 안전하게 관리할 수 있도록 합니다.
QIAGEN Digital Insights는 현재 전 세계에서 90,000명의 사용자를 지원하며, 25년의 산업 역사 동안 400만 환자 사례를 프로파일링했습니다. 이번 확장은 QIAGEN이 임상 차세대 시퀀싱(NGS) 테스트 서비스를 지원하고 데이터 보안, 규정 준수 및 운영 우수성을 전 세계적으로 보장하겠다는 의지를 보여줍니다.
QIAGEN (NYSE: QGEN) a annoncé l'ouverture d'un nouveau centre de données à Melbourne, Australie, élargissant ainsi son infrastructure mondiale de bioinformatique à huit installations dans le monde. Le nouveau centre servira la région Australie/Asie-Pacifique, y compris l'Australie, la Nouvelle-Zélande, la Nouvelle-Guinée et les îles environnantes.
La structure de Melbourne rejoint le réseau existant de centres de données de QIAGEN aux États-Unis, au Royaume-Uni, au Danemark, en Turquie, en Corée du Sud, au Japon et en Chine. Elle fournira des services d'hébergement de données dans le pays, permettant aux laboratoires de tests génomiques de se conformer aux réglementations australiennes en matière de confidentialité et de données de santé tout en gérant en toute sécurité des données sensibles.
QIAGEN Digital Insights sert actuellement 90 000 utilisateurs dans le monde et a profilé 4 millions de cas de patients au cours de ses 25 ans d'histoire dans l'industrie. L'expansion démontre l'engagement de QIAGEN à soutenir les services de tests cliniques de séquençage de nouvelle génération (NGS) et à garantir la sécurité des données, la conformité et l'excellence opérationnelle à l'échelle mondiale.
QIAGEN (NYSE: QGEN) hat die Eröffnung eines neuen Rechenzentrums in Melbourne, Australien bekannt gegeben und erweitert damit seine globale Bioinformatik-Infrastruktur auf acht Einrichtungen weltweit. Das neue Zentrum wird die Region Australien/Asien-Pazifik bedienen, einschließlich Australien, Neuseeland, Neuguinea und umliegenden Inseln.
Die Einrichtung in Melbourne ergänzt das bestehende Netzwerk von Rechenzentren von QIAGEN in den Vereinigten Staaten, im Vereinigten Königreich, in Dänemark, der Türkei, Südkorea, Japan und China. Sie wird nationale Datenhosting-Dienste bereitstellen, die es genomischen Testlaboren ermöglichen, die australischen Datenschutz- und Gesundheitsdatenvorschriften einzuhalten und dabei sensible Daten sicher zu verwalten.
QIAGEN Digital Insights bedient derzeit weltweit 90.000 Nutzer und hat in den 25 Jahren seiner Branchengeschichte 4 Millionen Patientendatensätze erfasst. Die Expansion zeigt das Engagement von QIAGEN, klinische Next-Generation-Sequencing (NGS) Testdienste zu unterstützen und die Datensicherheit, Compliance und operative Exzellenz weltweit zu gewährleisten.
- Expansion of global data center network to 8 facilities strengthens market presence
- Compliance with local Australian regulations enables market penetration
- Large existing user base of 90,000 users and 4 million profiled patient cases
- None.
Insights
The establishment of QIAGEN's Melbourne data center represents a strategically calculated move that extends beyond mere infrastructure expansion. This facility addresses several critical market dynamics that significantly enhance QIAGEN's competitive position in the rapidly growing Asia-Pacific bioinformatics market.
The timing of this expansion is particularly strategic, coinciding with increasing regulatory scrutiny around healthcare data sovereignty. Australia's stringent privacy and health data regulations have created a complex compliance landscape that many global competitors struggle to navigate. By establishing a local data center, QIAGEN has effectively created a significant barrier to entry, as competing services without local data hosting capabilities may face challenges in serving Australian healthcare institutions.
The investment carries substantial strategic value in three key areas:
- Market Access Enhancement: The facility enables QIAGEN to directly serve Australian healthcare institutions that require local data hosting, potentially unlocking a previously underserved market segment
- Competitive Differentiation: With eight global data centers, QIAGEN has built a robust infrastructure network that creates a compelling competitive advantage in data security and compliance - critical factors in healthcare decision-making
- Growth Platform: The Melbourne facility serves as a strategic hub for the broader Asia-Pacific region, positioning QIAGEN to capitalize on the region's rapidly growing genomics testing market
The facility's integration into QIAGEN's global network of data centers creates operational synergies that enhance their ability to serve multinational healthcare organizations while maintaining local compliance. This infrastructure investment significantly strengthens QIAGEN's position in the clinical NGS testing market, where data management capabilities are becoming increasingly critical to market success.
With 90,000 users worldwide and 4 million profiled patient cases, this expansion reinforces QIAGEN's market leadership while creating a foundation for sustained growth in the strategic Asia-Pacific region. The investment demonstrates a clear understanding of market dynamics and positions QIAGEN to capture a larger share of the expanding bioinformatics market.
-
New facility reflects QIAGEN’s commitment to enhancing its bioinformatics data center infrastructure in the
Australia ,New Zealand ,New Guinea and surrounding islands region
-
New data center in
Melbourne meets Australian regulations to ensure quality, scalable and trustworthy support for Omics analysis and interpretation in genomic testing labs
- Expands a QIAGEN network of seven data centers around the globe designed to ensure highest level of data security, compliance and operational excellence worldwide
VENLO,
This latest addition reflects QIAGEN’s ongoing commitment to enhance its bioinformatics data infrastructure, enabling initiatives to broaden the reach and use of bioinformatics products in the
It will also expand the current QIAGEN network of seven data centers strategically located across
This investment supports the expanding data center market in the
The new
”With the opening of this data center, we are strengthening our ability to serve the Australian market and the broader
As the use of clinical next-generating sequencing (NGS) continues to evolve, QIAGEN remains at the forefront, delivering innovative bioinformatics solutions that empower labs and researchers to unlock the full potential of genomics and personalized medicine.
With over 25 years of experience in the industry, 90,000 users worldwide, and 4 million profiled patient cases, QDI is committed to accelerating breakthroughs in science and healthcare by providing intuitive, scalable solutions that transform complex biological information into clear, actionable insights.
For more information about QIAGEN Digital Insights and its global data infrastructure, visit https://digitalinsights.qiagen.com/.
About QIAGEN
QIAGEN N.V., a
Forward-Looking Statement
Certain statements in this press release may constitute forward-looking statements within the meaning of Section 27A of the
Source: QIAGEN N.V.
Category: Corporate
View source version on businesswire.com: https://www.businesswire.com/news/home/20250213248826/en/
Contacts QIAGEN:
Investor Relations
John Gilardi +49 2103 29 11711
Domenica Martorana +49 2103 29 11244
e-mail: ir@QIAGEN.com
Public Relations
Thomas Theuringer +49 2103 29 11826
Lisa Specht +49 2103 29 14181
e-mail: pr@QIAGEN.com
Source: QIAGEN N.V.
FAQ
Where is QIAGEN's new data center located and what region does it serve?
How many global data centers does QIAGEN now operate after the Melbourne facility opening?
What is the purpose of QIAGEN's new Melbourne data center?
How many users does QIAGEN Digital Insights currently serve worldwide?
